Z M Thet Lwin1, S K Sahu2, P Owiti3, P Chinnakali4, S S Majumdar5. 1. Save the Children International, Yangon, Myanmar. 2. Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India. 3. Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya. 4. Department of Preventive and Social Medicine, JIPMER, Puducherry, India. 5. Centre for International Health, Burnet Institute, Melbourne, Victoria, Australia.
Abstract
Setting: The public-private mix (PPM) tuberculosis (TB) project implemented by the Myanmar Medical Association (MMA) in 105 townships in Myanmar. Objectives: 1) To assess the contribution of the MMA-PPM-TB project to total TB patient notification in the project townships; 2) to evaluate the outcomes of patients treated at the MMA-PPM clinics; and 3) to identify factors associated with unfavourable treatment outcomes, from January to December 2013. Design: A retrospective cohort study. Results: The MMA-PPM-TB project contributed 7501 (12%) of 60 905 TB patient notifications to the National Tuberculosis Programme (NTP) in 105 study townships. Of 2975 TB patients diagnosed and treated at private MMA-PPM clinics, 92% had a favourable outcome (32% cured, 60% completed treatment) and 8% had an unfavourable outcome (2.9% died, 2.5% lost to follow-up, 1.9% failure, 0.6% transfer out). Patient characteristics significantly associated with an unfavourable treatment outcome were age ⩾65 years (adjusted risk ratio [aRR] 5.7, 95% confidence interval [CI] 4.20-7.68), retreatment (aRR 2.44, 95%CI 1.79-3.33) and female sex (aRR 1.44, 95%CI 1.14-1.82). Conclusion: This study supports the continuation and expansion of the MMA-PPM-TB model and/or similar PPM approaches in Myanmar that engage all health providers in the ambitious goals of achieving universal health coverage in this country in transition and ending its TB epidemic by 2035.
Setting: The public-private mix (PPM) tuberculosis (TB) project implemented by the Myanmar Medical Association (MMA) in 105 townships in Myanmar. Objectives: 1) To assess the contribution of the MMA-PPM-TB project to total TB patient notification in the project townships; 2) to evaluate the outcomes of patients treated at the MMA-PPM clinics; and 3) to identify factors associated with unfavourable treatment outcomes, from January to December 2013. Design: A retrospective cohort study. Results: The MMA-PPM-TB project contributed 7501 (12%) of 60 905 TB patient notifications to the National Tuberculosis Programme (NTP) in 105 study townships. Of 2975 TB patients diagnosed and treated at private MMA-PPM clinics, 92% had a favourable outcome (32% cured, 60% completed treatment) and 8% had an unfavourable outcome (2.9% died, 2.5% lost to follow-up, 1.9% failure, 0.6% transfer out). Patient characteristics significantly associated with an unfavourable treatment outcome were age ⩾65 years (adjusted risk ratio [aRR] 5.7, 95% confidence interval [CI] 4.20-7.68), retreatment (aRR 2.44, 95%CI 1.79-3.33) and female sex (aRR 1.44, 95%CI 1.14-1.82). Conclusion: This study supports the continuation and expansion of the MMA-PPM-TB model and/or similar PPM approaches in Myanmar that engage all health providers in the ambitious goals of achieving universal health coverage in this country in transition and ending its TB epidemic by 2035.
Authors: G Ambe; K Lönnroth; Y Dholakia; J Copreaux; M Zignol; N Borremans; M Uplekar Journal: Int J Tuberc Lung Dis Date: 2005-05 Impact factor: 2.373
Authors: M Maung; H Kluge; T Aye; W Maung; P Noe; M Zaw; S P Jost; M Uplekar; K Lönnroth Journal: Int J Tuberc Lung Dis Date: 2006-09 Impact factor: 2.373
Authors: Eunice W Mailu; Philip Owiti; Serge Ade; Anthony D Harries; Marcel Manzi; Eunice Omesa; Polly Kiende; Stephen Macharia; Irene Mbithi; Maureen Kamene Journal: Trans R Soc Trop Med Hyg Date: 2019-12-01 Impact factor: 2.184
Authors: Stella Zawedde-Muyanja; Anja Reuter; Marco A Tovar; Hamidah Hussain; Aime Loando Mboyo; Anne K Detjen; Courtney M Yuen Journal: Pathogens Date: 2021-12-01